ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

EUFLEXXA
Arthritis/rheumatic disorders
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

EUFLEXXA Rx

Generic Name and Formulations:
Sodium hyaluronate 10mg/mL; soln for intra-articular inj.

Company:
Ferring Pharmaceuticals, Inc.

Therapeutic Use:

Indications for EUFLEXXA:

Osteoarthritis of the knee in patients who have failed nonpharmacologic therapy and analgesics (eg, acetaminophen).

Adult:

Prior to treatment: remove joint effusion (use separate syringe), if present. Inject 2mL (full syringe contents) intra-articularly in each affected knee weekly for 3 weeks. Use separate syringes for each knee.

Children:

Not recommended.

Contraindications:

Knee joint infection or skin disease at inj site.

Warnings/Precautions:

Repeated treatment cycles: not established. Avoid intravascular injection. Avoid strenuous activity within 48hrs after injection. Pregnancy. Nursing mothers.

Interactions:

Avoid disinfectants with quaternary ammonium salts. Concomitant other intra-articular injectables: not recommended.

Pharmacological Class:

Hyaluronan.

Adverse Reactions:

Arthralgia, increase blood pressure, inj site pain, local reactions, transient knee inflammation.

How Supplied:

Single-use prefilled syringes (2mL)—1

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs